KNOLL ANCROD SNAKE VENOM STROKE THERAPY PHASE III TRIALS
Executive Summary
KNOLL ANCROD SNAKE VENOM STROKE THERAPY PHASE III TRIALS are under way at Westchester County Medical Center. New York Medical College (NYMC) neurologists are running the 20-month double-blind, placebo-controlled trial to study the effect of ancrod (European trade name: Arvin), made from the venom of the Malayan pit viper, on ischemic stroke victims. The study is planned to involve approximately 450 subjects at 30 U.S. and Canadian centers, of which 25 have initiated trials thus far. NYMC announced the trial May 9. Phase III trials started in August 1993.